GPT and metabolic dysfunction-associated steatohepatitis: In contrast, the ratio of aspartate aminotransferase to alanine aminotransferase is considered to be an indicator of fibrosis progression, and cutoff values of 1.0 for nonalcoholic steatohepatitis and 0.8 for nonalcoholic fatty liver disease are recommended.